Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center

Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center

Purpose: Our study aimed to provide data on effectiveness, safety of crizotinib treatment, brain metastases, progression patterns, and sequential therapy beyond crizotinib treatment in patients with advanced ALK-positive NSCLC in China.Methods: We reviewed the medical records of crizotinib-treated N...

Full description

Bibliographic Details
Main Authors: Chang Liu, Hui Yu, Qianqian Long, Haiquan Chen, Yuan Li, Weixin Zhao, Kuaile Zhao, Zhengfei Zhu, Si Sun, Min Fan, Jianhua Chang, Jialei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
ALK
non-small-cell lung cancer
crizotinib
progression patterns
sequential therapy beyond crizotinib
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01116/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01116/full

Similar Items